rs2836391

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_182918.4(ERG):​c.237-10314C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.197 in 152,100 control chromosomes in the GnomAD database, including 3,122 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.20 ( 3122 hom., cov: 32)

Consequence

ERG
NM_182918.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.30

Publications

2 publications found
Variant links:
Genes affected
ERG (HGNC:3446): (ETS transcription factor ERG) This gene encodes a member of the erythroblast transformation-specific (ETS) family of transcriptions factors. All members of this family are key regulators of embryonic development, cell proliferation, differentiation, angiogenesis, inflammation, and apoptosis. The protein encoded by this gene is mainly expressed in the nucleus. It contains an ETS DNA-binding domain and a PNT (pointed) domain which is implicated in the self-association of chimeric oncoproteins. This protein is required for platelet adhesion to the subendothelium, inducing vascular cell remodeling. It also regulates hematopoesis, and the differentiation and maturation of megakaryocytic cells. This gene is involved in chromosomal translocations, resulting in different fusion gene products, such as TMPSSR2-ERG and NDRG1-ERG in prostate cancer, EWS-ERG in Ewing's sarcoma and FUS-ERG in acute myeloid leukemia. More than two dozens of transcript variants generated from combinatorial usage of three alternative promoters and multiple alternative splicing events have been reported, but the full-length nature of many of these variants has not been determined. [provided by RefSeq, Apr 2014]
ERG Gene-Disease associations (from GenCC):
  • lymphatic malformation 14
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.284 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_182918.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ERG
NM_182918.4
MANE Select
c.237-10314C>T
intron
N/ANP_891548.1P11308-4
ERG
NM_001136154.1
c.258-10314C>T
intron
N/ANP_001129626.1P11308-3
ERG
NM_001243428.1
c.258-10314C>T
intron
N/ANP_001230357.1P11308-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ERG
ENST00000288319.12
TSL:1 MANE Select
c.237-10314C>T
intron
N/AENSP00000288319.7P11308-4
ERG
ENST00000398919.6
TSL:1
c.258-10314C>T
intron
N/AENSP00000381891.2P11308-3
ERG
ENST00000398905.5
TSL:1
c.237-10314C>T
intron
N/AENSP00000381877.1B5MDW0

Frequencies

GnomAD3 genomes
AF:
0.197
AC:
29873
AN:
151982
Hom.:
3114
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.163
Gnomad AMI
AF:
0.397
Gnomad AMR
AF:
0.177
Gnomad ASJ
AF:
0.285
Gnomad EAS
AF:
0.205
Gnomad SAS
AF:
0.298
Gnomad FIN
AF:
0.155
Gnomad MID
AF:
0.222
Gnomad NFE
AF:
0.212
Gnomad OTH
AF:
0.204
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.197
AC:
29914
AN:
152100
Hom.:
3122
Cov.:
32
AF XY:
0.196
AC XY:
14541
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.163
AC:
6773
AN:
41478
American (AMR)
AF:
0.178
AC:
2722
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.285
AC:
989
AN:
3472
East Asian (EAS)
AF:
0.206
AC:
1065
AN:
5174
South Asian (SAS)
AF:
0.297
AC:
1426
AN:
4802
European-Finnish (FIN)
AF:
0.155
AC:
1643
AN:
10580
Middle Eastern (MID)
AF:
0.221
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
0.212
AC:
14433
AN:
67990
Other (OTH)
AF:
0.207
AC:
437
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1216
2432
3649
4865
6081
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
330
660
990
1320
1650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.189
Hom.:
539
Bravo
AF:
0.198
Asia WGS
AF:
0.258
AC:
900
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.074
DANN
Benign
0.70
PhyloP100
-2.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2836391; hg19: chr21-39805797; API